Key Market Indicators
Argentina's insulin importation is projected to decrease significantly by 2028. Current figures indicate that the country will import approximately $11.6 million worth of insulin by 2028, down from $18.8 million in 2023. This represents a year-on-year compound annual growth rate (CAGR) decline of 7.8%. Since 1998, the demand for insulin in Argentina has consistently fallen, averaging a 3.7% decrease annually. In contrast, Argentina's insulin exportation is expected to see a rise. Projections show that exports will reach $8 million by 2028, up from $6.8 million in 2023. This marks a year-on-year CAGR increase of 2.6%. Since 1998, Argentina's insulin supply has shown a positive trend, with an annual growth rate of 4.7%.
